3F-Thozalinone

3F-Thozalinone
Identifiers
  • (RS)-2-dimethylamino-5-(3-fluorophenyl)-1,3-oxazol-4-one
Chemical and physical data
FormulaC11H11FN2O2
Molar mass222.219 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • CN(C)C=1OC(c2cc(F)ccc2)C(=O)N=1

3F-Thozalinone (Frotozalinone) is a designer drug with stimulant effects, first reported in January 2026. It is the 3-fluoro derivative of thozalinone, and is related to drugs such as pemoline and 4'-Fluoro-4-methylaminorex.

See also

References

  1. ↑ Yurchenko R, Vydra T, Galetskaya I, Piatsetskaya A, Yurchenko L (January 2026). "Psychoactive products market observation. Trend analysis". Aipsin (73). doi:10.13140/RG.2.2.29396.05769.